Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Researchers are investigating treatments for participants with unresectable stage III Non-small Cell Lung Cancer NSCLC who have completed platinum-based concurrent chemoradiation therapy without disease progression. This Phase 3 randomized study compares the effects of two drugs, Pumitamig and Durvalumab, to evaluate their impact on progression-free survival and other clinical outcomes over several years. The trial is sponsored by Bristol-Myers Squibb and aims to better understand treatment options after initial chemoradiation. Participants are randomly assigned to receive either Pumitamig or Durvalumab monotherapy, each given at specified doses on specified days. The study treatment follows completion of concurrent chemoradiotherapy, with no masking or placebo involved. The trial includes an observation period lasting up to three years for primary outcome measures and extends up to approximately nine years for overall survival monitoring. During the study, participants will undergo regular assessments to monitor progression-free survival based on standardized imaging criteria, along with evaluations of overall survival, response rates, disease control, and treatment duration. These assessments are conducted by blinded independent reviewers and investigators. Participants will be monitored closely for safety and treatment effects throughout the trial, which spans several years from enrollment through long-term follow-up.
Actively Recruiting
Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating a digital health program called weSIPsmarter to reduce sugary drink consumption among preschool-aged children and their parents in rural areas. The study focuses on families involved in rural Head Start programs in Appalachia and the southern Black Belt, aiming to improve health behaviors and prevent chronic conditions related to high sugary drink intake. This trial addresses a gap in interventions designed for rural communities and young children aged 2 to 5 years. The study randomly assigns 12 rural Head Start programs to either the weSIPsmarter intervention or a control group called weLearn2Read. The weSIPsmarter program includes interactive behavioral components such as self-monitoring of beverage intake and parenting practices, goal setting, a resource help line, and water vouchers for families concerned about tap water quality. Participants in this group complete six learning modules, track daily sugary drink consumption, and parents also record daily weight. The control group completes six educational modules focused on reading readiness and receives childrens books and optional reminders. Participants, which are parent-child pairs from the Head Start programs, will be assessed at the start, after 9 weeks, and again at 12 months. Measurements include sugary drink intake, weight, height, body mass index, diet quality, and parent health literacy. Researchers will also study parent engagement, the programs reach, and how well it is adopted and maintained by the Head Start centers. Total participation spans over one year, with focus on both reducing sugary drink use and sustaining healthier behaviors over time.